Literature DB >> 16097446

p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.

Kyriakos Revelos1, Constantina Petraki, Alkiviadis Gregorakis, Andreas Scorilas, Panagiotis Papanastasiou, Roxane Tenta, Michael Koutsilieris.   

Abstract

The immunohistochemical expressions (IE) of p27(kip1) and Ki-67 (MIB-1), both involved in cell cycle regulation and cell proliferation, and their ability to predict biochemical failure, were assessed in patients with clinically localized prostate cancer who had underdone radical prostatectomy of curative intent. In addition, p27(kip1) and Ki-67 (MIB1) expressions were correlated with several pre-operative and post-operative parameters, such as Gleason score, extracapsular extension, seminal vesicle involvement, pelvic lymph nodes metastasis, positive surgical margins, coexistence of high-grade prostatic intraepithelial neoplasia, tumour size, prostate volume and PSA levels. Our analysis involved 130 consecutive radical prostatectomy specimens. A statistically significant correlation of low p27(kiP1) IE with seminal vesicles involvement, increased tumour volume and high pre-operative PSA values was documented. Low p27(kiP1) IE was significantly correlated with an increased likelihood of biochemical failure after radical prostatectomy. In addition, the increased IE of Ki-67 (MIB1) correlated significantly with metastatic disease in the pelvic lymph nodes and was a significant predictor of biochemical failure. Cox regression analysis, which included p27(kip1) expression, Ki-67 (MIB1) expression and all the pre-operative and post-operative parameters, showed that pelvic lymph node involvement and Ki-67 (MIB1) IE were independent prognostic markers of biochemical failure after radical prostatectomy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16097446

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  15 in total

1.  Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy.

Authors:  Raphaele Renard Penna; Geraldine Cancel-Tassin; Eva Comperat; Pierre Mozer; Priscilla Léon; Justine Varinot; Morgan Roupret; Marc-Olivier Bitker; Olivier Lucidarme; Olivier Cussenot
Journal:  World J Urol       Date:  2016-02-22       Impact factor: 4.226

2.  Multi-institutional validation of the prognostic value of Ki-67 labeling index in patients treated with radical prostatectomy.

Authors:  Romain Mathieu; Shahrokh F Shariat; Christian Seitz; Pierre I Karakiewicz; Harun Fajkovic; Maxine Sun; Yair Lotan; Douglas S Scherr; Ashutosh Tewari; Francesco Montorsi; Alberto Briganti; Morgan Rouprêt; Ilaria Lucca; Vitaly Margulis; Michael Rink; Luis A Kluth; Malte Rieken; Alexander Bachman; Evanguelos Xylinas; Brian D Robinson; Karim Bensalah; Markus Margreiter
Journal:  World J Urol       Date:  2014-10-26       Impact factor: 4.226

Review 3.  Molecular staging of prostate cancer in the year 2007.

Authors:  Thorsten Schlomm; Andreas Erbersdobler; Martina Mirlacher; Guido Sauter
Journal:  World J Urol       Date:  2007-03-02       Impact factor: 4.226

4.  Loss of p27(Kip1) CDKI is a predictor of poor recurrence-free and cancer-specific survival in patients with renal cancer.

Authors:  Ambrosi Pertia; David Nikoleishvili; Omar Trsintsadze; Nino Gogokhia; Laurent Managadze; Archil Chkhotua
Journal:  Int Urol Nephrol       Date:  2007-02-20       Impact factor: 2.370

5.  Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.

Authors:  Joseph Nariculam; Alex Freeman; Simon Bott; Phillipa Munson; Noriko Cable; Nicola Brookman-Amissah; Magali Williamson; Roger S Kirby; John Masters; Mark Feneley
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

6.  Immunoreactivity of p27(Kip1), cyclin D3, and Ki67 in conventional renal cell carcinoma.

Authors:  Ambrosi Pertia; David Nikoleishvili; Omar Trsintsadze; Nino Gogokhia; Laurent Managadze; Archil Chkhotua
Journal:  Int Urol Nephrol       Date:  2008-08-05       Impact factor: 2.370

7.  Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake.

Authors:  David M Schuster; Pooneh A Taleghani; Peter T Nieh; Viraj A Master; Rianot Amzat; Bital Savir-Baruch; Raghuveer K Halkar; Tim Fox; Adeboye O Osunkoya; Carlos S Moreno; Jonathon A Nye; Weiping Yu; Baowei Fei; Zhibo Wang; Zhengjia Chen; Mark M Goodman
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-01-05

8.  Prediction of prostate cancer recurrence using magnetic resonance imaging and molecular profiles.

Authors:  Amita Shukla-Dave; Hedvig Hricak; Nicole Ishill; Chaya S Moskowitz; Marija Drobnjak; Victor E Reuter; Kristen L Zakian; Peter T Scardino; Carlos Cordon-Cardo
Journal:  Clin Cancer Res       Date:  2009-05-12       Impact factor: 12.531

9.  Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer.

Authors:  Panagiotis J Vlachostergios; Foteini Karasavvidou; Grigorios Kakkas; Kassiani Kapatou; Ioannis Gioulbasanis; Danai D Daliani; George Moutzouris; Christos N Papandreou
Journal:  J Negat Results Biomed       Date:  2012-01-05

Review 10.  The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.

Authors:  Naveen Kachroo; Vincent J Gnanapragasam
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-28       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.